QUINSTREET, INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that QUINSTREET, INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Jun 30, 2015 | $282.14M | Aug 19, 2015 |
| FY2015 | Jun 30, 2014 | $282.55M | Aug 19, 2015 |
| FY2015 | Jun 30, 2013 | $305.10M | Aug 19, 2015 |
| FY2014 | Jun 30, 2012 | $370.47M | Sep 12, 2014 |
| FY2013 | Jun 30, 2011 | $403.02M | Aug 20, 2013 |
| FY2012 | Jun 30, 2010 | $334.84M | Aug 23, 2012 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $613.51M | Aug 21, 2024 |
| FY2024 | Jun 30, 2023 | $580.62M | Aug 21, 2024 |
| FY2024 | Jun 30, 2022 | $582.10M | Aug 21, 2024 |
| FY2023 | Jun 30, 2021 | $578.49M | Aug 21, 2023 |
| FY2022 | Jun 30, 2020 | $490.34M | Aug 22, 2022 |
| FY2021 | Jun 30, 2019 | $455.15M | Aug 26, 2021 |
| FY2020 | Jun 30, 2018 | $404.36M | Aug 28, 2020 |
| FY2019 | Jun 30, 2017 | $299.79M | Aug 29, 2019 |
| FY2018 | Jun 30, 2016 | $297.71M | Sep 12, 2018 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jun 30, 2017 | $299.79M | Sep 8, 2017 |
| FY2017 | Jun 30, 2016 | $297.71M | Sep 8, 2017 |
| FY2017 | Jun 30, 2015 | $282.14M | Sep 8, 2017 |
| FY2016 | Jun 30, 2014 | $282.55M | Aug 19, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $46.25M | Aug 21, 2024 |
| FY2024 | Jun 30, 2023 | $48.52M | Aug 21, 2024 |
| FY2024 | Jun 30, 2022 | $53.73M | Aug 21, 2024 |
| FY2023 | Jun 30, 2021 | $70.53M | Aug 21, 2023 |
| FY2022 | Jun 30, 2020 | $52.48M | Aug 22, 2022 |
| FY2021 | Jun 30, 2019 | $61.65M | Aug 26, 2021 |
| FY2020 | Jun 30, 2018 | $58.41M | Aug 28, 2020 |
| FY2019 | Jun 30, 2017 | $30.38M | Aug 29, 2019 |
| FY2018 | Jun 30, 2016 | $26.74M | Sep 12, 2018 |
| FY2017 | Jun 30, 2015 | $30.14M | Sep 8, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | ($31.33M) | Aug 21, 2024 |
| FY2024 | Jun 30, 2023 | ($68.87M) | Aug 21, 2024 |
| FY2024 | Jun 30, 2022 | ($5.25M) | Aug 21, 2024 |
| FY2023 | Jun 30, 2021 | $23.56M | Aug 21, 2023 |
| FY2022 | Jun 30, 2020 | $18.10M | Aug 22, 2022 |
| FY2021 | Jun 30, 2019 | $62.48M | Aug 26, 2021 |
| FY2020 | Jun 30, 2018 | $15.93M | Aug 28, 2020 |
| FY2019 | Jun 30, 2017 | ($12.21M) | Aug 29, 2019 |
| FY2018 | Jun 30, 2016 | ($19.42M) | Sep 12, 2018 |
| FY2017 | Jun 30, 2015 | ($20.01M) | Sep 8, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | ($28.07M) | Aug 21, 2024 |
| FY2024 | Jun 30, 2023 | ($20.82M) | Aug 21, 2024 |
| FY2024 | Jun 30, 2022 | ($4.72M) | Aug 21, 2024 |
| FY2023 | Jun 30, 2021 | $13.93M | Aug 21, 2023 |
| FY2022 | Jun 30, 2020 | $6.21M | Aug 22, 2022 |
| FY2021 | Jun 30, 2019 | $10.73M | Aug 26, 2021 |
| FY2020 | Jun 30, 2018 | $15.64M | Aug 28, 2020 |
| FY2019 | Jun 30, 2017 | ($10.66M) | Aug 29, 2019 |
| FY2018 | Jun 30, 2016 | ($18.87M) | Sep 12, 2018 |
| FY2017 | Jun 30, 2015 | ($19.18M) | Sep 8, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $30.05M | Aug 21, 2024 |
| FY2024 | Jun 30, 2023 | $28.89M | Aug 21, 2024 |
| FY2024 | Jun 30, 2022 | $21.91M | Aug 21, 2024 |
| FY2023 | Jun 30, 2021 | $19.34M | Aug 21, 2023 |
| FY2022 | Jun 30, 2020 | $14.21M | Aug 22, 2022 |
| FY2021 | Jun 30, 2019 | $12.33M | Aug 26, 2021 |
| FY2020 | Jun 30, 2018 | $13.81M | Aug 28, 2020 |
| FY2019 | Jun 30, 2017 | $13.48M | Aug 29, 2019 |
| FY2018 | Jun 30, 2016 | $16.43M | Sep 12, 2018 |
| FY2017 | Jun 30, 2015 | $17.95M | Sep 8, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $12.04M | Aug 21, 2024 |
| FY2024 | Jun 30, 2023 | $11.84M | Aug 21, 2024 |
| FY2024 | Jun 30, 2022 | $28.67M | Aug 21, 2024 |
| FY2023 | Jun 30, 2021 | $50.62M | Aug 21, 2023 |
| FY2022 | Jun 30, 2020 | $47.61M | Aug 22, 2022 |
| FY2021 | Jun 30, 2019 | $37.97M | Aug 26, 2021 |
| FY2020 | Jun 30, 2018 | $26.98M | Aug 28, 2020 |
| FY2019 | Jun 30, 2017 | $18.54M | Aug 29, 2019 |
| FY2018 | Jun 30, 2016 | $1.02M | Sep 12, 2018 |
| FY2013 | Jun 30, 2013 | $51.92M | Aug 20, 2013 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $5.35M | Aug 21, 2024 |
| FY2024 | Jun 30, 2023 | $3.06M | Aug 21, 2024 |
| FY2024 | Jun 30, 2022 | $2.84M | Aug 21, 2024 |
| FY2023 | Jun 30, 2021 | $1.97M | Aug 21, 2023 |
| FY2022 | Jun 30, 2020 | $1.96M | Aug 22, 2022 |
| FY2021 | Jun 30, 2019 | $1.97M | Aug 26, 2021 |
| FY2020 | Jun 30, 2018 | $610.0K | Aug 28, 2020 |
| FY2019 | Jun 30, 2017 | $1.16M | Aug 29, 2019 |
| FY2018 | Jun 30, 2016 | $1.86M | Sep 12, 2018 |
| FY2017 | Jun 30, 2015 | $3.35M | Sep 8, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $368.55M | Aug 21, 2024 |
| FY2024 | Jun 30, 2023 | $337.16M | Aug 21, 2024 |
| FY2023 | Jun 30, 2022 | $419.91M | Aug 21, 2023 |
| FY2022 | Jun 30, 2021 | $449.52M | Aug 22, 2022 |
| FY2021 | Jun 30, 2020 | $358.41M | Aug 26, 2021 |
| FY2020 | Jun 30, 2019 | $324.61M | Aug 28, 2020 |
| FY2019 | Jun 30, 2018 | $220.30M | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | $174.31M | Sep 12, 2018 |
| FY2017 | Jun 30, 2016 | $193.10M | Sep 8, 2017 |
| FY2016 | Jun 30, 2015 | $205.15M | Aug 19, 2016 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $151.72M | Aug 21, 2024 |
| FY2024 | Jun 30, 2023 | $107.35M | Aug 21, 2024 |
| FY2023 | Jun 30, 2022 | $133.91M | Aug 21, 2023 |
| FY2022 | Jun 30, 2021 | $154.37M | Aug 22, 2022 |
| FY2021 | Jun 30, 2020 | $102.46M | Aug 26, 2021 |
| FY2020 | Jun 30, 2019 | $101.78M | Aug 28, 2020 |
| FY2019 | Jun 30, 2018 | $71.97M | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | $56.23M | Sep 12, 2018 |
| FY2017 | Jun 30, 2016 | $68.35M | Sep 8, 2017 |
| FY2016 | Jun 30, 2015 | $69.57M | Aug 19, 2016 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $216.83M | Aug 21, 2024 |
| FY2024 | Jun 30, 2023 | $229.80M | Aug 21, 2024 |
| FY2024 | Jun 30, 2022 | $286.00M | Aug 21, 2024 |
| FY2023 | Jun 30, 2021 | $295.15M | Aug 21, 2023 |
| FY2023 | Jun 30, 2020 | $255.94M | Aug 21, 2023 |
| FY2022 | Jun 30, 2019 | $222.83M | Aug 22, 2022 |
| FY2021 | Jun 30, 2018 | $148.33M | Aug 26, 2021 |
| FY2020 | Jun 30, 2017 | $118.08M | Aug 28, 2020 |
| FY2019 | Jun 30, 2016 | $124.75M | Aug 29, 2019 |
| FY2018 | Jun 30, 2015 | $135.59M | Sep 12, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $125.06M | Aug 21, 2024 |
| FY2024 | Jun 30, 2023 | $121.14M | Aug 21, 2024 |
| FY2023 | Jun 30, 2022 | $121.14M | Aug 21, 2023 |
| FY2023 | Jun 30, 2021 | $117.83M | Aug 21, 2023 |
| FY2022 | Jun 30, 2020 | $80.68M | Aug 22, 2022 |
| FY2021 | Jun 30, 2019 | $82.54M | Aug 26, 2021 |
| FY2020 | Jun 30, 2018 | $62.28M | Aug 28, 2020 |
| FY2019 | Jun 30, 2017 | $56.12M | Aug 29, 2019 |
| FY2018 | Jun 30, 2016 | $56.12M | Sep 12, 2018 |
| FY2016 | Jun 30, 2015 | $56.12M | Aug 19, 2016 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | ($130.41M) | Aug 21, 2024 |
| FY2024 | Jun 30, 2023 | ($99.08M) | Aug 21, 2024 |
| FY2023 | Jun 30, 2022 | ($30.21M) | Aug 21, 2023 |
| FY2022 | Jun 30, 2021 | ($24.97M) | Aug 22, 2022 |
| FY2021 | Jun 30, 2020 | ($48.52M) | Aug 26, 2021 |
| FY2020 | Jun 30, 2019 | ($66.62M) | Aug 28, 2020 |
| FY2019 | Jun 30, 2018 | ($129.10M) | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | ($145.03M) | Sep 12, 2018 |
| FY2017 | Jun 30, 2016 | ($132.83M) | Sep 8, 2017 |
| FY2016 | Jun 30, 2015 | ($113.41M) | Aug 19, 2016 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $50.49M | Aug 21, 2024 |
| FY2024 | Jun 30, 2023 | $73.68M | Aug 21, 2024 |
| FY2024 | Jun 30, 2022 | $96.44M | Aug 21, 2024 |
| FY2023 | Jun 30, 2021 | $110.32M | Aug 21, 2023 |
| FY2022 | Jun 30, 2020 | $107.51M | Aug 22, 2022 |
| FY2021 | Jun 30, 2019 | $62.52M | Aug 26, 2021 |
| FY2020 | Jun 30, 2018 | $64.70M | Aug 28, 2020 |
| FY2019 | Jun 30, 2017 | $49.57M | Aug 29, 2019 |
| FY2018 | Jun 30, 2016 | $53.71M | Sep 12, 2018 |
| FY2018 | Jun 30, 2015 | $60.47M | Sep 12, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | 0 | Aug 21, 2024 |
| FY2024 | Jun 30, 2023 | (1) | Aug 21, 2024 |
| FY2024 | Jun 30, 2022 | 0 | Aug 21, 2024 |
| FY2023 | Jun 30, 2021 | 0 | Aug 21, 2023 |
| FY2022 | Jun 30, 2020 | 0 | Aug 22, 2022 |
| FY2021 | Jun 30, 2019 | 1 | Aug 26, 2021 |
| FY2020 | Jun 30, 2018 | 0 | Aug 28, 2020 |
| FY2019 | Jun 30, 2017 | 0 | Aug 29, 2019 |
| FY2018 | Jun 30, 2016 | 0 | Sep 12, 2018 |
| FY2017 | Jun 30, 2015 | 0 | Sep 8, 2017 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | 0 | Aug 21, 2024 |
| FY2024 | Jun 30, 2023 | (1) | Aug 21, 2024 |
| FY2024 | Jun 30, 2022 | 0 | Aug 21, 2024 |
| FY2023 | Jun 30, 2021 | 0 | Aug 21, 2023 |
| FY2022 | Jun 30, 2020 | 0 | Aug 22, 2022 |
| FY2021 | Jun 30, 2019 | 1 | Aug 26, 2021 |
| FY2020 | Jun 30, 2018 | 0 | Aug 28, 2020 |
| FY2019 | Jun 30, 2017 | 0 | Aug 29, 2019 |
| FY2018 | Jun 30, 2016 | 0 | Sep 12, 2018 |
| FY2017 | Jun 30, 2015 | 0 | Sep 8, 2017 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | 55.47M | Aug 21, 2024 |
| FY2024 | Jun 30, 2023 | 54.19M | Aug 21, 2024 |
| FY2023 | Jun 30, 2022 | 53.36M | Aug 21, 2023 |
| FY2022 | Jun 30, 2021 | 53.79M | Aug 22, 2022 |
| FY2021 | Jun 30, 2020 | 52.21M | Aug 26, 2021 |
| FY2020 | Jun 30, 2019 | 50.52M | Aug 28, 2020 |
| FY2019 | Jun 30, 2018 | 48.15M | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | 45.44M | Sep 12, 2018 |
| FY2017 | Jun 30, 2016 | 45.56M | Sep 8, 2017 |
| FY2016 | Jun 30, 2015 | 44.62M | Aug 19, 2016 |